Abbott Confirms Long-Term Commitment to HIV Care
Abbott plans to develop two new formulations of its HIV medicines, Kaletra (lopinavir/ritonavir) and Norvir...
Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
Novartis has started shipping seasonal influenza vaccine to its US customers for the 2011-2012 influenza...
XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted marketing authorization for...
Roche provides update from FDA hearing on Avastin for metastatic breast cancer
Roche announced that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic...
Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company...
Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
Pfizer Inc. (NYSE: PFE) is exploring strategic alternatives for its Animal Health and Nutrition businesses...
Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement
Bristol-Myers Squibb Company (NYSE: BMY) and Innate Pharma S.A. (Euronext Paris: FR0010331421, IPH) announced a...
Amgen and UCB Team Up with NASA on Final Space Shuttle Mission
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) are collaborating with the National Aeronautics and...
Medical Research Council Finds Antibody Capable of Fighting Flu
An antibody that can fight all types of the influenza A virus has been identified...
GlaxoSmithKline and Valeant announce US FDA approval of Potiga
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the U.S. Food and Drug Administration (FDA)...